These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5941235)

  • 21. [First experience in the long term treatment with the antihypertensive Guancydin including studies of the renin-angiotensin system].
    Werning C; Schweikert HU; Stiel D; Vetter W; Siegenthaler W
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1756-61. PubMed ID: 5451983
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of hypotensive treatment in a hospital environment].
    Pavesi V; Campus G
    Minerva Med; 1968 May; 59(40):2345-50. PubMed ID: 5653333
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial with 2-guanidinomethyl (1,4) benzodioxan in hypertension.
    Malhotra RP; Khurana SB; Singh S
    J Indian Med Assoc; 1967 Jan; 48(2):69-74. PubMed ID: 6038525
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and statistical considerations on a new drug in the therapy of arterial hypertension. Controlled study].
    Antognetti R; Giovine GG
    Minerva Cardioangiol; 1984 May; 32(5):313-23. PubMed ID: 6382056
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medico-social aspects of arterial hypertension and clinical considerations on its treatment with the guanoxane-polythiazide combination].
    Di Benedetto A; Di Blasi S
    Minerva Med; 1967 Mar; 58(21):893-6. PubMed ID: 6026542
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of arterial hypertension with a new drug combining guanabenz-mefruside].
    Frisina N; Macrì I; Ussi F
    Minerva Cardioangiol; 1984 May; 32(5):325-32. PubMed ID: 6382057
    [No Abstract]   [Full Text] [Related]  

  • 27. [Guanfacine: controlled clinical study in arterial hypertension].
    Lauro R
    Clin Ter; 1980 May; 93(4):439-55. PubMed ID: 6998644
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
    Wambach G; Breuer G; Kaufmann W
    Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Saluretic action of angiotensin II in essential and renovascular hypertension].
    Zeneroli ML
    Endocrinol Sci Cost; 1970 Jul; 31(3):195-200. PubMed ID: 4323807
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive action and renal effects of guanabenz].
    Pessina AC; Milani L; Gatta A; Hlede M; Amodio P; Palatini P; Frigo A; Semplicini A; Casiglia E; Merkel C
    Minerva Cardioangiol; 1984 May; 32(5):285-90. PubMed ID: 6472628
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trial of compound 1029 (vatensol).
    Srivastava BN; Gupta RK; Harshvardhan ; Goswami SL
    Indian Heart J; 1966 Oct; 18(4):333-44. PubMed ID: 5977540
    [No Abstract]   [Full Text] [Related]  

  • 33. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of idiopathic hypertension with guanabenz-mefruside].
    Tomasi AM; Pirani R; Masoni C
    Minerva Cardioangiol; 1984 May; 32(5):339-44. PubMed ID: 6382059
    [No Abstract]   [Full Text] [Related]  

  • 35. [First clinical experiences with a blood pressure lowering imidazole compound].
    Kühns K; Frisius H; Oloffs J
    Dtsch Med Wochenschr; 1966 Dec; 91(49):2205-9. PubMed ID: 5926930
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O; Valenzuela MA; Salazar R
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract]   [Full Text] [Related]  

  • 39. [The place of guanfacine in the treatment of essential arterial hypertension].
    Koaté P; Diouf S; Sylla M; Sarr M; Ba SA
    Dakar Med; 1983; 28(2):321-36. PubMed ID: 6360603
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical use of atenolol (Tenormin) in arterial hypertension].
    Beloev I; Popiliev I; Tŭrnovska R; Pelov R
    Vutr Boles; 1982; 21(4):36-41. PubMed ID: 6755910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.